Myeloblastic leukemia

Myeloblastic leukemia is a type of cancer that affects the blood and bone marrow. It is characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells. Myeloblastic leukemia is also known as acute myeloid leukemia (AML).

Symptoms

The symptoms of myeloblastic leukemia can vary, but may include fatigue, fever, weight loss, and bleeding or bruising easily. Other symptoms may include shortness of breath, pale skin, and frequent infections.

Causes

The exact cause of myeloblastic leukemia is unknown, but it is believed to be caused by a combination of genetic and environmental factors. Certain genetic disorders, such as Down syndrome, and exposure to certain chemicals or radiation can increase the risk of developing this disease.

Diagnosis

Myeloblastic leukemia is typically diagnosed through a series of tests, including blood tests, bone marrow tests, and genetic testing. These tests can help determine the type and stage of the leukemia, which can guide treatment decisions.

Treatment

Treatment for myeloblastic leukemia typically involves chemotherapy, and may also include radiation therapy, stem cell transplant, or other targeted therapies. The goal of treatment is to destroy the leukemia cells and allow normal cells to form in the bone marrow.

Prognosis

The prognosis for myeloblastic leukemia can vary depending on a number of factors, including the patient's age, overall health, and the specific type and stage of the leukemia.

See also

• Leukemia
• Acute lymphoblastic leukemia
• Chronic myeloid leukemia
• Chronic lymphocytic leukemia

Myeloblastic leukemia Resources
Latest articles Most recent articles Ongoing trials	Wikipedia